These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1151699)

  • 1. Characterization of habits and crystalline modification of solids and their pharmaceutical applications.
    Haleblian JK
    J Pharm Sci; 1975 Aug; 64(8):1269-88. PubMed ID: 1151699
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug formulation and biologic availability.
    Poole JW
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceutical sciences-1974: literature review of pharmaceutics.
    Haleblian JK; Goodhart FW
    J Pharm Sci; 1975 Jul; 64(7):1085-148. PubMed ID: 1151675
    [No Abstract]   [Full Text] [Related]  

  • 4. General principles of pharmaceutical solid polymorphism: a supramolecular perspective.
    Rodríguez-Spong B; Price CP; Jayasankar A; Matzger AJ; Rodríguez-Hornedo N
    Adv Drug Deliv Rev; 2004 Feb; 56(3):241-74. PubMed ID: 14962581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The discovery and investigation of a crystalline solid solution of an active pharmaceutical ingredient.
    Patel MA; AbouGhaly MHH; Chadwick K
    Int J Pharm; 2017 Oct; 532(1):166-176. PubMed ID: 28847668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracking of crystalline-amorphous transition of carvedilol in rotary spun microfibers and their formulation to orodispersible tablets for in vitro dissolution enhancement.
    Szabó P; Sebe I; Stiedl B; Kállai-Szabó B; Zelkó R
    J Pharm Biomed Anal; 2015 Nov; 115():359-67. PubMed ID: 26280924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical transformation of niclosamide solvates in pharmaceutical suspensions determined by DSC and TG analysis.
    de Villiers MM; Mahlatji MD; Malan SF; van Tonder EC; Liebenberg W
    Pharmazie; 2004 Jul; 59(7):534-40. PubMed ID: 15296091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polymorph transformation of solid drugs].
    Zhang Q; Mei XF
    Yao Xue Xue Bao; 2015 May; 50(5):521-7. PubMed ID: 26234130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
    Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
    Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
    Parikh T; Sandhu HK; Talele TT; Serajuddin AT
    Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural characterization, physicochemical properties, suspension stability, and adsorption properties of four solid forms of amitraz.
    de Villiers MM; van Eeden CM; Liebenberg W; Song M; Kolling WM; Caira MR
    J Agric Food Chem; 2004 Dec; 52(24):7362-9. PubMed ID: 15563220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement.
    Murdande SB; Pikal MJ; Shanker RM; Bogner RH
    Pharm Dev Technol; 2011 Jun; 16(3):187-200. PubMed ID: 20429826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simplified method for determining chemical stability of drug substances in pharmaceutical suspensions.
    Tingstad J; Dudzinski J; Lachman L; Shami E
    J Pharm Sci; 1973 Aug; 62(8):1361-3. PubMed ID: 4725189
    [No Abstract]   [Full Text] [Related]  

  • 14. Stability of extemporaneous pediatric oral liquids compounded from tablets and drug substance: case of propranolol and theophylline.
    Muśko M; Sznitowska M
    Acta Pol Pharm; 2013; 70(1):137-45. PubMed ID: 23610969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of crystallinity on the rate of solution of oxytetracycline hydrochloride].
    Grakovskaia LK; Nesterova LIa
    Antibiotiki; 1982 Nov; 27(11):815-20. PubMed ID: 7181463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Physical Stability of Amorphous Drug Formulations via Dry Polymer Coating.
    Capece M; Davé R
    J Pharm Sci; 2015 Jun; 104(6):2076-2084. PubMed ID: 25902736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubility prediction, solvate and cocrystal screening as tools for rational crystal engineering.
    Loschen C; Klamt A
    J Pharm Pharmacol; 2015 Jun; 67(6):803-11. PubMed ID: 25851032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-situ determination of crystallization kinetics in ASDs via water sorption experiments.
    Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2018 Jun; 127():183-193. PubMed ID: 29477357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystallization of amorphous indomethacin during dissolution: effect of processing and annealing.
    Greco K; Bogner R
    Mol Pharm; 2010 Oct; 7(5):1406-18. PubMed ID: 20459092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.